SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-13-004692
Filing Date
2013-04-23
Accepted
2013-04-23 08:17:39
Documents
3
Period of Report
2013-06-12
Effectiveness Date
2013-04-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2214489zdef14a.htm DEF 14A 484597
2 G18202CAI001.GIF g18202cai001.gif GRAPHIC 53962
3 G18202CAI002.GIF g18202cai002.gif GRAPHIC 36268
  Complete submission text file 0001047469-13-004692.txt   610445
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 13775209
SIC: 2835 In Vitro & In Vivo Diagnostic Substances